Central sleep apnea device increases mortality in heart failure
Tuesday, September 1, 2015 - 12:00
in Health & Medicine
Adaptive servo-ventilation (ASV) therapy increases mortality and should not be used to treat central sleep apnea in heart failure patients with reduced ejection fraction, the SERVE-HF trial shows.